Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Similar documents
Routine internal quality control as recommended by EUCAST Version 3.1, valid from

European Committee on Antimicrobial Susceptibility Testing

European Committee on Antimicrobial Susceptibility Testing

EUCAST recommended strains for internal quality control

What s new in EUCAST methods?

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

BSAC standardized disc susceptibility testing method (version 8)

British Society for Antimicrobial Chemotherapy

British Society for Antimicrobial Chemotherapy

Version 9.1 March 2010

Antimicrobial Susceptibility Testing: The Basics

2015 Antibiotic Susceptibility Report

Version 10.1 April 2011

Advanced Practice Education Associates. Antibiotics

Antimicrobial Susceptibility Testing: Advanced Course

Version 13 January 2014

AMR Industry Alliance Antibiotic Discharge Targets

EUCAST-and CLSI potency NEO-SENSITABS

Version 8 January 2009

2016 Antibiotic Susceptibility Report

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

Version 6, January 2007

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

Version 7, January 2008

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

January 2014 Vol. 34 No. 1

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

QUICK REFERENCE. Pseudomonas aeruginosa. (Pseudomonas sp. Xantomonas maltophilia, Acinetobacter sp. & Flavomonas sp.)

National Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults

Performance Information. Vet use only

56 Clinical and Laboratory Standards Institute. All rights reserved.

January 2014 Vol. 34 No. 1

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

ESCMID Online Lecture Library. by author

Antimicrobial susceptibility

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

CONTAGIOUS COMMENTS Department of Epidemiology

Antimicrobial Susceptibility Patterns

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Penicillins - EUCAST clinical MIC breakpoints (version 1.3)

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

Intrinsic, implied and default resistance

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

Practical approach to Antimicrobial susceptibility testing (AST) and quality control

RCH antibiotic susceptibility data

Antimicrobial susceptibility testing challenges. Linda Joyce St Vincent s Hospital Melbourne

Quality assurance of antimicrobial susceptibility testing

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

CONTAGIOUS COMMENTS Department of Epidemiology

This document is protected by international copyright laws.

TABLE OF CONTENTS. Urine - Gram Positive Susceptibility Reporting 1 Staphylococcus species, MRSA...11

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

GENERAL NOTES: 2016 site of infection type of organism location of the patient

- the details, where possible, of the antibiotic products these companies supply or have supplied.

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

Principles of Antibiotics Use & Spectrum of Some

CONTAGIOUS COMMENTS Department of Epidemiology

Bacterial Pathogens in Urinary Tract Infection and Antibiotic Susceptibility Pattern from a Teaching Hospital, Bengaluru, India

HUSRES Annual Report 2007 Martti Vaara.

Concise Antibiogram Toolkit Background

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Version 1.01 (01/10/2016)

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli. CRL Training course in AST Copenhagen, Denmark 23-27th Feb.

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Understanding the Hospital Antibiogram

Taiwan Surveillance of Antimicrobial Resistance (TSAR)

Antibiotic Updates: Part II

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

Principles of Infectious Disease. Dr. Ezra Levy CSUHS PA Program

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

Approach to pediatric Antibiotics

Antibiotic Susceptibility of Common Bacterial Pathogens in Canine Urinary Tract Infections

microbiology testing services

Antimicrobial susceptibility testing of Campylobacter jejuni and C. coli

M45: INFREQUENTLY ISOLATED OR FASTIDIOUS BACTERIA

Mongolia September 2012

CUMULATIVE ANTIBIOGRAM

Transcription:

Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to implementation and consumables. Media: Media BSAC EUCAST For non fastidious organisms IsoSensitest Agar (ISO) Mueller Hinton Agar (MHA) For fastidious organisms * Mechanically defibrinated IsoSensitest Agar + 5% defibrinated horse blood + 20mg/L β NAD (ISON) Mueller Hinton Agar + 5% defibrinated horse blood* + 20mg/L β NAD (MH F) Storage and drying of media plates are the same for both methods with one exception: EUCAST: For Campylobacter jejuni & Campylobacter coli: In order to reduce swarming, the MH F plates should be dried prior to inoculation (at 20 25 C overnight, or at 35 C, with the lid removed, for 15 min). Inoculum: Inoculum confluence The table below is a comparison of BSAC and EUCAST inoculum confluence using Table 3 from the BSAC guidelines. Organism BSAC EUCAST For Enterobacteriaceae, Acinetobacter spp., Pseudomonas spp., S. maltophilia, enterococci, β haemolytic streptococci, H. influenzae, P. multocida, B. fragilis & B. thetaiotaomicron. For staphylococci, Serratia spp., S. pneumoniae, α haemolytic streptococci, M. catarrhalis, N. meningitidis, Corynebacterium spp., Clostridium perfringens. For N. gonorrhoeae, Campylobacter spp. Semi confluent 1:100 dilution of 0.5 McFarland density Semi confluent 1:100 dilution of 0.5 McFarland density Semi confluent 0.5 McFarland density Confluent 0.5 McFarland density (See exception 1) Confluent 0.5 McFarland density (except S. pneumoniae from Chocolate agar: McFarland 1) (See exception) Confluent 0.5 McFarland density (See exception)

Exception: Disc diffusion criteria for antimicrobial susceptibility testing of anaerobes, C. difficile, N. meningitidis & N. gonorrhoeae have not yet been defined and an MIC method should be used. Inoculum preparation: Inoculum preparation BSAC EUCAST Inoculum fluid Preparation method Sterile water or IsoSensitest broth Direct colony suspension or growth method Sterile saline Direct colony suspension Both methods recommend use of the inoculum within 15 minutes. Inoculation of media: Both methods use a similar method for inoculating media & recommend application of discs within 15 minutes. Antimicrobial disc concentrations: Concentrations of most antimicrobials in discs are the same for BSAC and EUCAST. The following table shows the antimicrobial discs with different concentrations to those used for BSAC: Antimicrobial BSAC content (ug) EUCAST content (ug) Comment Enterobacteriaceae Ampicillin/sulbactam Not available 10/10 Amoxicillin 10 Not available Use ampicillin Piperacillin 75 30 Piperacillin/tazobactam 75/10 30/6 Temocillin 30 Not available as yet Ticarcillin Not available 75 Cefadroxil Not available 30 Cefotaxime 30 5 Ceftazidime 30 10 Ceftibuten Not available 30 Pefloxacin Not available 5 Cipro screen for

Levofloxacin 1 5 Nalidixic acid 30 Not available Norfloxacin 2 10 Netilmicin Not available 10 Azithromycin 15 Not available as yet Tetracycline 10 Not available as yet Fosfomycin 200/50 Not available as yet Nitrofurantoin 200 100 Trimethoprim 2.5 5 Salmonella spp. Use ciprofloxacin for screen instead. Acinetobacter species Piperacillin/tazobactam 75/10 Not available Levofloxacin Not available 5 Netilmicin Not available 10 Tobramycin Not available 10 Co trimoxazole* Not available 1.25/23.75 Pseudomonas species Piperacillin 75 30 Piperacillin/tazobactam 75/10 30/6 Cefepime Not available 30 Ceftazidime 30 10 Ciprofloxacin 1 OR 5 5 Staphylococcus species Testing of β lactams not reliable. Ampicillin 25 2 Cefoxitin 10 30 Oxacillin 1 Not available Use cefoxitin Norfloxacin Not available 10 of ciprofloxacin to screen Neomycin 10 Not available Perform MIC Netilmicin Not available 10 Azithromycin 15 Not available Use erythromycin Clarithromycin 2 Not available Use erythromycin Doxycycline 30 Not available Use tetracycline

Chloramphenicol 10 30 Trimethoprim (UTI) 2.5 5 Fosfomycin 200/50 Not available as yet Mupirocin 20 200 Nitrofurantoin (UTI) 200 100 Rifampicin 2 5 S. pneumoniae Cefaclor Not available 30 Levofloxacin 1 5 Norfloxacin Not available 10 of ciprofloxacin to screen Teicoplanin Not available 30 Azithromycin 15 Not available Use erythromycin Clarithromycin 2 Not available Same as BSAC Telithromycin 15 15 Same as BSAC Minocycline Not available 30 Chloramphenicol 10 30 Enterococcus species Amoxicillin 10 Not available Use ampicillin Ampicillin 10 2 Ciprofloxacin Not available 5 Levofloxacin Not available 5 Norfloxacin (screen) Not available 10 Gentamicin 200 30 Nitrofurantoin 200 100 Trimethoprim 2.5 5 Co trimoxazole* Not available 1.25/23.75 Alpha haemolytic streptococci Amoxicillin 2 Not available Use ampicillin Ampicillin Not available 2 Cefazolin Not available 30 Cefepime Not available 30 of Benzylpenicillin Ceftriaxone Not available 30 of Benzylpenicillin Cefuroxime Not available 30 of Benzylpenicillin

Linezolid 10 Not available as yet Beta haemolytic streptococci Levofloxacin Not available 5 Moxifloxacin Not available 5 Norfloxacin (screen) Not available 10 Teicoplanin Not available 30 Vancomycin Not available 5 Azithromycin 15 Not available Use erythromycin Clarithromycin 2 Not available Use erythromycin Minocycline Not available 30 Chloramphenicol Not available 30 Trimethoprim 2.5 5 Nitrofurantoin 200 100 Rifampicin Not available 5 M. catarrhalis Cefaclor 30 Not available Cefepime Not available 30 Cefixime Not available 5 Cefotaxime Not available 5 Cefpodoxime Not available 10 Ceftriaxone Not available 30 Cefuroxime (oral & iv) 5 30 Doripenem Not available 10 Imipenem Not available 10 Meropenem Not available 10 Levofloxacin 1 5 Clarithromycin 2 Not available Use erythromycin Minocycline Not available 30 Chloramphenicol 10 30 H. influenzae Ampicillin/sulbactam Not available 10/10 Amoxicillin 2 Not available Use ampicillin Benzylpenicillin (screen) Not available 1 unit Screen for β lactam resistance Cefepime Not available 30 Cefixime Not available 5 Cefpodoxime Not available 10

Ceftibuten Not available 30 Cefuroxime (oral & iv) 5 30 Doripenem Not available 10 Levofloxacin 1 5 Azithromycin 15 Not available Use erythromycin Clarithromycin 5 Not available Use erythromycin Minocycline Not available 30 Chloramphenicol 10 30 Rifampicin (prophylaxis) Not available 5 Pasteurella multocida Ampicillin 10 2 Co amoxiclav* Not available 2/1 Cefotaxime Not available 5 Ciprofloxacin Not available 5 Levofloxacin Not available 5 Tetracycline (screen) Not available 30 Campylobacter species Nalidixic acid 30 Not available Use ciprofloxacin Tetracycline Not available 30 Corynebacterium species (except C. diphtheriae) Moxifloxacin Not available 5 Gentamicin Not available 10 Clindamycin Not available 2 Tetracycline Not available 30 Linezolid Not available 10 Rifampicin Not available 5 Gram negative anaerobes Co amoxiclav 20/10 Not available as yet Piperacillin/tazobactam 75/10 Not available as yet Meropenem 10 Not available as yet Clindamycin 2 Not available as yet Metronidazole 5 Not available as yet Gram positive anaerobes (except C. difficile)

Benzylpenicillin 1 unit Not available as yet Meropenem 10 Not available as yet Clindamycin 2 Not available as yet Metronidazole 5 Not available as yet Listeria species Benzylpenicillin Not available 1 unit Ampicillin Not available 2 Meropenem Not available 10 Erythromycin Not available 15 Co trimoxazole* Not available 1.25/23.75 * The following antimicrobial combinations are referred to differently in BSAC & EUCAST: Co amoxiclav (BSAC) & Amoxicillin/clavulanic acid (EUCAST) Co trimoxazole (BSAC) & Trimethoprim sulfamethoxazole Storage & handling of discs is similar for both methods. Application of discs: Application of discs is similar for both methods, including recommending incubation within 15 minutes of application. Incubation conditions: Below is a table of incubation conditions for BSAC and EUCAST methods. Organism BSAC EUCAST Enterobactericeae 35 37 C in air for 35±1 C in air for Pseudomonas spp. 35 37 C in air for 35±1 C in air for Acinetobacter spp. 35 37 C in air for 35±1 C in air for S. maltophilia 30 C in air for 35±1 C in air for Staphylococcus spp. (other than oxacillin/cefoxitin) Staphylococcus spp. (using cefoxitin) Staphylococcus spp. (using oxacillin) 35 37 C in air for 35±1 C in air for 35 C in air for 35±1 C in air for 30 C in air for 24h Not applicable, use cefoxitin. Enterococcus spp. 35 37 C in air for 35 37 C in air for 24h for 35±1 C in air for 35±1 C in air for 24h for

β haemolytic streptococci (grps A,B,C,G) haemolytic streptococci (viridans) S. pneumoniae H. influenzae M. catarrhalis P. multocida Coryneform bacteria Campylobacter jejuni / coli Listeria monocytogenes N. meningitidis / gonorrhoeae B. fragilis, B. thetaiotaomicron, C. perfringens glycopeptides 35 37 C in air for 42 C in microaerophilic* conditions for 24h No method available 35 37 C in 10% CO 2 /10% H 2 /80% N 2 for glycopeptides. Isolates with insufficient growth after are reincubated and read at 40 48h. 41±1 C in microaerobic* environment for 24h. Isolates with insufficient growth after 24h are reincubated and read at 40 48h. No method available No method available * Microaerophilic & microaerobic are both terms for conditions with low oxygen levels.

Control organisms: The following lists the organisms used to control quality in the BSAC and EUCAST disc diffusion methods. Organism BSAC EUCAST E. coli NCTC 10418 / ATCC 10536 or NCTC 12241/ ATCC 25922 NCTC 12241 / ATCC 25922 E. coli (TEM 1 β lactamase producer) NCTC 11560 ATCC 35218 / NCTC 11954 K. pneumoniae Not available P. aeruginosa S. aureus NCTC 10662 / ATCC 25668 or ATCC 27853 / NCTC 12903 NCTC 6571 or ATCC 25923 / NCTC 12981 ATCC 700603 / NCTC 13368 ESBL producer ATCC 27853 / NCTC 12903 ATCC 29213 / NCTC 12973 S. aureus (MRSA, MecA positive) NCTC 12493 NCTC 12493 E. faecalis ATCC 29212 / NCTC 12697 ATCC 29212 / NCTC 12697 E. faecalis (HL gentamicin resistant) Not available ATCC 51299 / NCTC 13379 VanB positive S. pneumoniae ATCC 49619 / NCTC 12977 ATCC 49619 / NCTC 12977 H. influenzae NCTC 11931 ATCC 49766 / NCTC 12975 H. influenzae (β lactamase negative, ampicillin resistant) ATCC 49247 / NCTC 12699 ATCC 49247 / NCTC 12699 Campylobacter jejuni Not available ATCC 33560 / NCTC11351 N. gonorrhoeae NCTC 12700 / ATCC 49226 Not available P. multocida NCTC 8489 Use H. influenzae ATCC 49766 / NCTC 12975 B. fragilis NCTC 9343 / ATCC 25285 Not available